Literatur
Buendgens L, Koch A, Tacke F et al (2016) Prevention of stress-related ulcer bleeding at the intensive care unit: risks and benefits of stress ulcer prophylaxis. World J Crit Care Med 5:57–64
Buendgens L, Tacke F (2017) Do we still need pharmacological stress ulcer prophylaxis at the ICU? J Thorac Dis 9:4201–4204
Stadlbauer V (2018) Protonenpumpenhemmer für den Intensivpatienten. Sorgfältige Patientenselektion und Strategien zum Nebenwirkungsmanagement. Wien Klin Mag 21:48–53
Fischbach W, Malfertheiner P, Lynen Jansen P et al (2016) S2k-Leitlinie Helicobacter pylori und gastroduodenale Ulkuskrankheit. Z Gastroenterol 54:351–352
Cook DJ, Fuller HD, Guyatt GH et al (1994) Risk factors for gastrointestinal bleeding in critically ill patients. Canadian Critical Care Trials Group. N Engl J Med 330(6):377–381
Krag M, Perner A, Wetterslev J et al (2014) Stress ulcer prophylaxis versus placebo or no prophylaxis in critically ill patients. A systematic review of randomized clinical trials with meta-analysis and trial sequential analysis. Intensive Care Med 40:11–22
Alhazzani W, Alshamsi F, Belley-Cote E et al (2018) Efficacy and safety of stress ulcer prophylaxis in critically ill patients: a network meta-analysis of randomized trials. Intensive Care Med 44(1):1–11
Alhazzani W, Guyatt G, Alshahrani M et al (2017) Withholding Pantoprazole for stress ulcer prophylaxis in critically ill patients: a pilot randomized clinical trial and meta-analysis. Crit Care Med 7:1121–1129
Alshamsi F, Belley-Cote E, Cook D et al (2016) Efficacy and safety of proton pump inhibitors for stress ulcer prophylaxis in critically ill patients: a systematic review and meta-analysis of randomized trials. Crit Care 20(1):120
Reynolds PM, MacLaren R (2018) Re-evaluating the utility of stress ulcer prophylaxis in the critically ill patient: a clinical scenario-based meta-analysis. Pharmacotherapy. https://doi.org/10.1002/phar.2172
Alhazzani W, Alenezi F, Jaeschke RZ et al (2013) Proton pump inhibitors versus histamine 2 receptor antagonists for stress ulcer prophylaxis in critically ill patients: a systematic review and meta-analysis. Crit Care Med 41(3):693–705
Liu B, Liu S, Yin A et al (2015) Risks and benefits of stress ulcer prophylaxis in adult neurocritical care patients: a systematicreview and meta-analysis of randomized controlled trials. Crit Care 19:40
Vaezi MF, Yang YX, Howden CW (2017) Complication of proton pump inhibitor therapy. Baillieres Clin Gastroenterol 153:35–48
Freedberg DE, Kim LSY (2017) The risks and benefitsis of long-term use of proton pump inhibitors: expert review and best practise advice from the American Gastroenterological Association. Baillieres Clin Gastroenterol 152:706–715
Rhodes A, Evans LE, Alhazzani W et al (2017) Surviving Sepsis Campaign. Crit Care Med 45(3):486–552
Rhodes A, Evans LE, Alhazzani W et al (2017) Surviving Sepsis Campaign: international guidelines for management of sepsis and septic shock: 2016. Intensive Care Med 43(3):340–341
Werdan K, Ruß M, Buerke M (2011) Deutsch-österreichische S3-Leitlinie „Infarktbedingter kardiogener Schock – Diagnose, Monitoring und Therapie“. Kardiologe 5:213
Adamzik A, Bauer A, Bein TH (2017) S3-Leitlinie-Invasive Beatmung und Einsatz extrakorporaler Verfahren bei akuter respiratorischer Insuffizienz. AWMF-Leitlinienregister Nr. 001 /021, S 1–295
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Interessenkonflikt
P. Kasper, U. Janssens und G. Michels geben an, dass kein Interessenkonflikt besteht.
Additional information
Redaktion
S. Kluge, Hamburg
Rights and permissions
About this article
Cite this article
Kasper, P., Janssens, U. & Michels, G. Welchen Stellenwert haben Protonenpumpeninhibitoren im Rahmen der Prophylaxe von Stressulzerationen und stressassoziierten gastrointestinalen Blutungen bei Patienten auf Intensivstation?. Med Klin Intensivmed Notfmed 114, 350–354 (2019). https://doi.org/10.1007/s00063-018-0515-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00063-018-0515-x